Biomethylation platform
Our biomethylation platform enables efficient biosynthesis of methylated compounds through precision fermentation by enhancing intracellular regeneration of S-adenosylmethionine (SAM), a key methyl donor. This approach addresses a major bottleneck in metabolic engineering, where limited SAM availability restricts production yields and scalability.
By improving cofactor efficiency within microbial systems, the platform allows cost-effective and scalable production of high-value methylated molecules for flavors, fragrances, and health-related applications. We are exploring target compounds and applications with partners and are open to collaboration for PoC development, strain engineering, and commercialization pathways.
About Mitsubishi Chemical Corporation
Mitsubishi Chemical Corporation is a major chemical company that develops and manufactures a wide range of high-performance chemicals, polymers, and resins. The organization focuses on creating sustainable material solutions, including bio-based engineering plastics, to address environmental challenges and meet the evolving needs of global markets. Their research and development efforts aim to reduce reliance on fossil resources through innovative material science and sustainable production processes.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.